Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Hydrazine; L-amino acid decarboxylase inhibitor...
Flavonoid found in Epimedium sagittatum.
Polyether Ca2+ ionophore.
Endogenous bombesin-like peptide, involved in f...
Diterpene vitamin A; RAR/RXR agonist.
Sulfonylurea; ATP-sensitive K+ channel blocker....
Endogenous tachykinin peptide, involved in infl...
Nucleoside antibiotic mixture; GlcNAc phosphotr...
Nucleoside (deoxyguanosine) analog, ganciclovir...
Cdc42 inhibitor.
Polyene macrolide; ergosterol inhibitor.
Endogenous cardiomodulatory peptide; NPR-A agon...
Casein kinase 1α/δ/ε inhibitor.
A peroxisome proliferator-activated receptor ag...
Bactericidal
NSAID; NMDA inverse agonist, T-type Ca2+ and Cl...
Synthetic glutathione peroxidase mimetic; yeast...
PKA inhibitor, potential ROCK, S6K1, MSK1, PKB ...
Mycotoxin derivative; actin polymerization inhi...
RET, EGFR, VEGFR2 inhibitor.